Rocket Pharmaceuticals (RCKT) Interest Coverage Ratio (2014 - 2026)
Rocket Pharmaceuticals (RCKT) reported Interest Coverage Ratio of 102.56 for Q1 2026, up 24.82% on a YoY basis from 82.17 in Q1 2025, and down 10.35% sequentially from 92.95 in Q4 2025.
Rocket Pharmaceuticals (RCKT) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 13 years of Interest Coverage Ratio data on file, last reported at 102.56 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 24.82% year-over-year to 102.56; the trailing twelve-month figure through Mar 2026 stood at 114.16 (up 20.28% YoY), and the FY2025 full-year result was 1.74, up 17.73% from the prior year.
- Interest Coverage Ratio slipped to 102.56 in Q1 2026, from 92.95 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.5 in Q1 2022 to a low of 156.5 in Q2 2024.
- A 5-year average of 70.6 and a median of 92.95 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio tumbled 28536.42% in 2024 and surged 99.25% in 2025, its largest moves.
- Tracing RCKT's Interest Coverage Ratio over 5 years: stood at 147.93 in 2022, then advanced by 8.98% to 134.64 in 2023, then rose by 1.55% to 132.55 in 2024, then increased by 29.88% to 92.95 in 2025, then slipped by 10.35% to 102.56 in 2026.
- Business Quant data shows RCKT's Interest Coverage Ratio at 102.56 in Q1 2026, 92.95 in Q4 2025, and 1.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Rocket Pharmaceuticals | 357.93 Mn | 357.93 Mn | - | -102.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.56 |
| Dec 31, 2025 | -92.95 |
| Sep 30, 2025 | -1.10 |
| Jun 30, 2025 | -1.49 |
| Mar 31, 2025 | -136.42 |
| Dec 31, 2024 | -132.55 |
| Sep 30, 2024 | -147.40 |
| Jun 30, 2024 | -156.50 |
| Mar 31, 2024 | -143.05 |
| Dec 31, 2023 | -134.64 |
| Sep 30, 2023 | -0.51 |
| Jun 30, 2023 | -0.57 |
| Mar 31, 2023 | -0.64 |
| Dec 31, 2022 | -147.93 |
| Sep 30, 2022 | -0.66 |
| Jun 30, 2022 | -0.75 |
| Mar 31, 2022 | -0.50 |
| Dec 31, 2021 | -95.75 |
| Sep 30, 2021 | -0.24 |
| Jun 30, 2021 | -0.10 |